The Most Favored Nation Policy: early insights into Europe’s response
On 12 May 2025, US President Donald Trump signed an executive order directing the US Department of Health and Human…
All articles by Simran Gurung
Simran Gurung
-
-
Orphan drug landscape in the 7MM: launch patterns, market trends, and HTA insights
Orphan drugs are therapeutics developed to address rare diseases typically defined by patient population thresholds that vary across regions: fewer…
-
5EU Q1 2024 versus 2025: Pricing shifts, HTA outcomes, and innovative drug trends
To assess the impact of pharmaceutical policy and market dynamics on market access, GlobalData has conducted a comparative analysis of…